Maze Therapeutics rises on $150M equity offering (MAZE:NASDAQ)


  • Maze Therapeutics (NASDAQ:MAZE) shares rose over 45% premarket on Thursday after the biopharmaceutical company announced an oversubscribed private placement of its securities to raise gross proceeds of approximately $150.0 million.
  • The offering includes 4,000,002 shares at $16.25 each, a premium to the



Source link

5 missing Spotify features I want that would make it way better

BBC Confirms Agatha Christie Drama & Greenlights ‘The Hairdresser Mysteries’

Leave a Reply

Your email address will not be published. Required fields are marked *